Regulation of vascular permeability by vascular endothelial growth factors

Vascular Pharmacology

Volumn 39, Issue 4-5, 2002, Pages 225-237

  Bates, D O ^a   Harper, S J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Calcium; Endothelium; Hydraulic conductivity; Transcellular gaps; TRPC channels; Vascular permeability; VEGF; VVO

Indexed keywords

VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN A;

ANGIOGENESIS; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; CANCER; DIABETES MELLITUS; HEART DISEASE; INTERSTITIUM; MACROMOLECULE; PHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STROKE; TISSUE REPAIR; VASCULAR DISEASE; VASCULARIZATION; VASODILATATION; ANIMAL; CELL MEMBRANE PERMEABILITY; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL MEMBRANE PERMEABILITY; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0041842763     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(03)00011-9     Document Type: Review

References (131)

1. Abell R.G. The permeability of blood capillary sprouts and newly formed blood capillaries as compared to that of older capillaries. Am. J. Physiol. 147:1946;231-241.
2. Aiello L.P., Wong J.S. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int. 58:2000;113-119.
3. Albelda S.M., et al. Permeability characteristics of cultured endothelial cell monolayers. J. Appl. Physiol.: Respir. Environ. Exerc. Physiol. 64:1988;308-322.
4. Bates D.O. The chronic effect of vascular endothelial growth factor on individually perfused frog mesenteric microvessels. J. Physiol. 513:1998;225-233.
5. Bates D.O. Vascular endothelial growth factor (VEGF) chronically increases microvascular hydraulic conductivity (Lp) without affecting oncotic reflection coefficient (s). FASEB J. 1998;A22.
6. Bates D.O., Curry F.E. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am. J. Physiol. Heart Circ. Physiol. 271:1996;H2520-H2528.
7. 2+-dependent pathway. Am. J. Physiol. Heart Circ. Physiol. 273:1997;H687-H694.
8. Bates D.O., et al. Vascular endothelial growth factor and microvascular permeability. Microcirculation. 6:1999;83-96.
9. Bates D.O., et al. Vascular endothelial growth factor increases Rana vascular permeability and compliance by different signalling pathways. J. Physiol. 533:2001;263-272.
10. 165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res. 62:2002;4123-4131.
11. Bates D.O., et al. Regulation of microvascular permeability by vascular endothelial growth factors. J. Anat. 200:2002;581-597.
12. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature. 361:1993;315-325.
13. 2+ and von Willebrand factor release in human endothelial cells. Am. J. Pathol. 138:1991;213-221.
14. Brown L.F., et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol. 143:1993;1255-1262.
15. Bull R.H., et al. Intravital video-capillaroscopy for the study of the microcirculation in psoriasis. Br. J. Dermatol. 126:1992;436-445.
16. Celletti F.L., et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat. Med. 7:2001;425-429.
17. Clark E.R., Clark E.L. Observations on changes in blood vascular endothelium in the living animal. Am. J. Anat. 57:1935;385-438.
18. Clough G., et al. Inflammatory changes in permeability and ultrastructure of single vessels in the frog mesenteric microcirculation. J. Physiol. 395:1988;99-114.
19. Collins P.D., et al. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br. J. Pharmacol. 109:1993;195-199.
20. Connolly D.T., et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84:1989;1470-1478.
21. Couffinhal T., et al. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am. J. Pathol. 150:1997;1673-1685.
22. Crandall D.L., et al. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation. 4:1997;211-232.
23. Criscuolo G.R., et al. Further characterization of malignant glioma-derived vascular permeability factor. J. Neurosurg. 69:1988;254-262.
24. Criscuolo G.R., et al. Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity. J. Neurosurg. 71:1989;884-891.
25. Curry F.E. Mechanics and thermodynamics of transcapillary exchange. Michel C.C., Renkin E.M. Handbook of Physiology. The Cardiovascular System. Microcirculation. 2nd ed. 1984;309-373 American Physiological Society, Bethesda, MD.
26. Curry F.E. Modulation of venular microvessel permeability by calcium influx into endothelial cells. FASEB J. 6:1992;2456-2466.
27. Curry F.E., et al. Techniques in microcirculation: measurement of permeability, pressure and flow. Linden R.J. Cardiovascular Physiology. Techniques in the Life Sciences. 1983;1-34 Elsevier, New York.
28. Damert A., et al. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res. 57:1997;3860-3864.
29. Dejana E., et al. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb. Haemost. 86:2001;308-315.
30. Detmar M., et al. Overexpression of vascular permeability factor/ vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180:1994;1141-1146.
31. de Vries C., et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 255:1992;989-991.
32. Doanes A.M., et al. VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases. Biochem. Biophys. Res. Commun. 255:1999;545-548.
33. Dvorak A.M., et al. The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J. Leukoc. Biol. 59:1996;100-115.
34. Dvorak H.F., et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 237:1999;97-132.
35. Esser S., et al. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 140:1998;947-959.
36. Favard C., et al. Purification and biological properties of vasculotropin, a new angiogenic cytokine. Biol. Cell. 73:1991;1-6.
37. Feng D., et al. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J. Exp. Med. 183:1996;1981-1986.
38. Feng D., et al. Reinterpretation of endothelial cell gaps induced by vasoactive mediators in guinea-pig, mouse and rat: many are transcellular pores. J. Physiol. 504:1997;747-761.
39. Feng D., et al. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation. 6:1999;23-44.
40. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell Physiol. 280:2001;C1358-C1366.
41. Ferrara N., Bunting S. Vascular endothelial growth factor, a specific regulator of angiogenesis. Curr. Opin. Nephrol. Hypertens. 5:1996;35-44.
42. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 18:1997;4-25.
43. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:1989;851-858.
44. Fong T.A., et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 59:1999;99-106.
45. 2+]i through VEGF-R2 activation of TrpC6 channels. J. Vasc. Res. 39:2002;552.
46. Fu B.M., Shen S. Structural mechanisms of acute VEGF effect on microvessel permeability. Am. J. Physiol. Heart Circ. Physiol. 2003;. 10.1152/ajpheart.00894.2002.
47. Gerber H.P., et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273:1998;30336-30343.
48. Gingras D., et al. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins. Biochem. J. 348:2000;273-280.
49. Guo D., et al. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270:1995;6729-6733.
50. He P., et al. Measurement of cytoplasmic calcium in single microvessels with increased permeability. Am. J. Physiol. 258:1990;H1366-H1374.
51. Hillman N.J., et al. Microvessel endothelial cell ultrastructure after vascular endothelial growth factor-C (VEGF-C) induced chronically increased Lp. J. Vasc. Res. 38:2000;195.
52. Hillman N.J., et al. Differential effects on microvascular hydraulic conductivity (Lp) of vascular endothelial growth factor C (VEGF-C) and placental growth factor-1 (PlGF-1). J. Vasc. Res. 38:2001;176-185.
53. Hippenstiel S., et al. VEGF induces hyperpermeability by a direct action on endothelial cells. Am. J. Physiol. Lung and Resp. Physiol. 274:1998;L678-L684.
54. Hofman P., et al. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A. Curr. Eye Res. 21:2000;637-645.
55. Hofmann T., et al. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature. 397:1999;259-263.
56. Hollerhage H.G., et al. The influence of nimodipine on cerebral blood flow autoregulation and blood-brain barrier. J. Neurosurg. 69:1988;919-922.
57. Houck K.A., et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5:1991;1806-1814.
58. Houck K.A., et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267:1992;26031-26037.
59. Hudlicka O. Development of the microcirculation: capillary growth and adaptation. Michel C.C., Renkin E.M. Handbook of Physiology. The Cardiovascular System. Microcirculation. 2nd ed. 1984;165-216 American Physiological Society, Bethesda, MD.
60. Hudlicka O., et al. Angiogenesis in skeletal and cardiac muscle. Physiol. Rev. 72:1992;369-417.
61. Iwasaka C., et al. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J. Cell. Physiol. 169:1996;522-531.
62. Jingjing L., et al. Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 40:1999;752-759.
63. Joukov V., et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:1996;290-298.
64. Keck P.J., et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 246:1989;1309-1312.
65. Keyt B.A., et al. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem. 271:1996;7788-7795.
66. Keyt B.A., et al. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem. 271:1996;5638-5646.
67. Ku D.D., et al. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. Heart Circ. Physiol. 265:1993;H586-H592.
68. Lakshminarayanan S., et al. Effect of VEGF on retinal microvascular endothelial hydraulic conductivity: the role of NO. Invest. Ophthalmol. Vis. Sci. 41:2000;4256-4261.
69. Landis E.M., Pappenheimer J.R. Exchange of substances through the capillary walls. Hamilton W.F., Dows P. Handbook of Physiology, Circulation. 1963;961-1034 American Physiological Society, Washington, DC.
70. Leung D.W., et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
71. Levick J.R. An Introduction to Cardiovascular Physiology. 1991;Butterworths, London.
72. Liu Z.Y., et al. Characterization of signal transduction pathways in human bone marrow endothelial cells. Blood. 90:1997;2253-2259.
73. Mack C.A., et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg. 115:1998;168-176. (discussion 176-177).
74. Majno G., et al. Endothelial contraction induced by histamine-type mediators: an electron microscopic study. J. Cell Biol. 42:1969;647-672.
75. Makinen T., et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20:2001;4762-4773.
76. Michel C.C. Fluid movements through capillary walls. Michel C.C., Renkin E.M. Handbook of Physiology. The Cardiovascular System. Microcirculation. 2nd ed. 1984;375-409 American Physiological Society, Bethesda, MD.
77. Michel C.C. Transport of macromolecules through microvascular walls. Cardiovasc. Res. 32:1996;644-653.
78. Michel C.C., Phillips M.E. Steady-state fluid filtration at different capillary pressures in perfused frog mesenteric capillaries. J. Physiol. 388:1987;421-435.
79. Michel C.C., et al. A development of the Landis technique for measuring the filtration coefficient of individual capillaries in the frog mesentery. Q. J. Exp. Physiol. Cog. Med. Sci. 59:1974;283-309.
80. Miles A., Miles E. Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea pigs. J. Physiol. 118:1952;228-257.
81. Mukhopadhyay D., et al. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature. 375:1995;577-581.
82. Mukhopadhyay D., et al. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium. Cancer Res. 58:1998;1278-1284.
83. Neal C.R., Michel C.C. Vascular endothelial growth factor (VEGF) increases permeability by inducing openings through endothelial cells. Int. J. Microcirc. Clin. Exp. 17:1997;198.
84. Neal C.R., Michel C.C. Differing effects of vascular endothelial growth factor (VEGF) on the ultrastructure of mesenteric microvessels of frog and rat. J. Physiol. 1998;24P.
85. Neal C.R., Michel C.C. Ultrastructural changes in microvascular endothelium associated with increased permeability. J. Vasc. Res. 35:1998;388.
86. Neufeld G., et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:1999;9-22.
87. Nie D., et al. Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem. Biophys. Res. Commun. 267:2000;245-251.
88. Parenti A., et al. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J. Biol. Chem. 273:1998;4220-4226.
89. Park J.E., et al. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269:1994;25646-25654.
90. Pearce S.C., et al. Effect of indomethacin on capillary growth and microvasculature in chronically stimulated rat skeletal muscles. J. Physiol. 526:2000;435-443.
91. Pocock T.M., Bates D.O. In vivo mechanisms of vascular endothelial growth factor-mediated increased hydraulic conductivity of Rana capillaries. J. Physiol. 534:2001;479-488.
92. Pocock T.M., Bates D.O. VEGF-induced increased microvascular hydraulic conductivity (Lp) is not mediated through protein kinase C. Proc. 7th World Congr. Microcirc. Sydney ANZMCS. 2002.
93. i) in frog mesenteric microvessels in vivo. J. Vasc. Res. 39:2002;548.
94. Pocock T.M., Bates D.O. Effect of flufenamic acid on VEGF mediated increased hydraulic conductivity (Lp) in frog mesenteric microvessels. J. Physiol. 2003;. 547P C105.
95. i. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H1625-H1634.
96. Poltorak Z., et al. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J. Biol. Chem. 272:1997;7151-7158.
97. Potgens A.J., et al. Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. J. Biol. Chem. 269:1994;32879-32885.
98. Roberts W.G., Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108:1995;2369-2379.
99. Ruhrberg C.H., et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes. Dev. 16:2002;2684-2698.
100. Sandner P., et al. Induction of VEGF and VEGF receptor gene expression by hypoxia: divergent regulation in vivo and in vitro. Kidney Int. 51:1997;448-453.
101. Schoefl G.I. Studies on inflammation. III. Growing capillaries: their structure and permeability. Virchows Arch. Pathol. Anat. 337:1963;97-141.
102. Seetharam L., et al. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene. 10:1995;135-147.
103. Senger D.R., et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:1983;983-985.
104. Senger D.R., et al. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 46:1986;5629-5632.
105. Senger D.R., et al. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res. 50:1990;1774-1778.
106. Smaje L.H., et al. The distensibility of single capillaries and venules in the cat mesentery. Microvasc. Res. 20:1980;358-370.
107. Soker S., et al. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J. Biol. Chem. 271:1996;5761-5767.
108. Soker S., et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:1998;735-745.
109. Spanel-Borowski K., Mayerhofer A. Formation and regression of capillary sprouts in corpora lutea of immature superstimulated golden hamsters. Acta Anat. (Basel). 128:1987;227-235.
110. Taherzadeh M., Warren J.B. Comparison of diltiazem and verapamil on rat microvascular permeability. Microvasc. Res. 54:1997;206-213.
111. Taylor A.E., Granger D.N. Exchange of macromolecules across the microcirculation. Michel C.C., Renkin E.M. Handbook of Physiology. The Cardiovascular System. Microcirculation. 1984;467-520 American Physiological Society, Bethesda, MD.
112. Terman B.I., et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187:1992;1579-1586.
113. Tischer E., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:1991;11947-11954.
114. van Bruggen N., et al. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J. Clin. Invest. 104:1999;1613-1620.
115. Vaquero J., et al. Expression of vascular permeability factor in glioblastoma specimens: correlation with tumor vascular endothelial surface and peritumoral edema. J. Neurooncol. 49:2000;49-55.
116. Wenger R.H., et al. Hypoxia-inducible factor-1alpha is regulated at the post-mRNA level. Kidney Int. 51:1997;560-563.
117. Wheeler-Jones C., et al. Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS. Lett. 420:1997;28-32.
118. Whittle C., et al. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. Clin. Sci. (Colch.). 97:1999;303-312.
119. 148) stimulates endothelial cell proliferation. J. Vasc. Res. 39:2002;S1-S64.
120. Whittles C.E., et al. ZM323881, a novel inhibitor of vascular endothelial growth factor receptor (VEGFR) kinase activity blocks VEGF-mediated increases in microvascular permeability in vivo. Microcirculation. 9:2002;513-522.
121. Wood J.M., et al. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 60:2000;2178-2189.
122. Wu H.M., et al. VEGF induces NO-dependent hyperpermeability in coronary venules. Am. J. Physiol. Heart Circ. Physiol. 271:1996;H2735-H2739.
123. Wu H.M., et al. Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am. J. Physiol. 276:1999;H535-H542.
124. Wu L.W., et al. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J. Biol. Chem. 275:2000;5096-5103.
125. Xia P., et al. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J. Clin. Invest. 98:1996;2018-2026.
126. Xu L., et al. Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. Int. J. Oncol. 16:2000;445-454.
127. Yano S., et al. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Clin. Cancer Res. 6:2000;957-965.
128. Yano K., et al. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J. Clin. Invest. 107:2001;409-417.
129. Zachary I., Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc. Res. 49:2001;568-581.
130. Zhang H.T., et al. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br. J. Cancer. 83:2000;63-68.
131. Zhou Z., et al. A novel alternative splicing isoform of vascular endothelial growth factor gene in human beings. Zhōnghuá Ȳixué Zázhì 2002;82.